SCHEMBL6607075

SCHEMBL6607075

CCO[Si](C)(C)C(C)(C)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6608086 0.81
SCHEMBL9243242 0.79 TSHR (0.30)
SCHEMBL6857336 0.74 FAAH (0.33)
SCHEMBL370773 0.73 DUT (0.30)
SCHEMBL3664502 0.65
SCHEMBL17359792 0.65
SCHEMBL3333990 0.63
SCHEMBL301818 0.63 TSHR (0.30)
SCHEMBL18231797 0.62 TSHR (0.30)
SCHEMBL7551845 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032561-B1 SUBSTITUTED OXIMES AS NEUROKININ ANTAGONISTS SCHERING CORP (US) 2004-02-11 EP disclosed
EP-1032561-A1 SUBSTITUTED OXIMES AS NEUROKININ ANTAGONISTS SCHERING CORPORATION (US) 2000-09-06 EP disclosed
US-6063926-A HAVING GREATER BIOACTIVITY SCHERING CORPORATION (US) 2000-05-16 US disclosed
WO-1999026924-A1 SUBSTITUTED OXIMES AS NEUROKININ ANTAGONISTS SCHERING CORPORATION (US) 1999-06-03 WO disclosed